77 related articles for article (PubMed ID: 2816882)
1. Low doses of H2 antagonists and interaction with anticholinergics.
Savarino V; Mela GS; Celle G
Am J Gastroenterol; 1989 Nov; 84(11):1463-4. PubMed ID: 2816882
[No Abstract] [Full Text] [Related]
2. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
3. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A
Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
[TBL] [Abstract][Full Text] [Related]
4. Daily gastric pH in controls and in duodenal ulcer patients: basal condition and response to treatment.
Masoero G; Rossanino A; Arossa W; Marchetto M; Marucci M; De la Pierre M
Am J Gastroenterol; 1988 Feb; 83(2):136-42. PubMed ID: 3341336
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Maculotti L; Pradella P
Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
7. [The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
Vakhrushev IaM; Muravtseva OV
Eksp Klin Gastroenterol; 2002; (2):29-31, 101. PubMed ID: 12046381
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
[TBL] [Abstract][Full Text] [Related]
9. Prolonged gastric pH monitoring in responder and nonresponder duodenal ulcer patients: response to placebo and to H2-blocker administration.
Masoero G; Rossanino A; Arossa W; De la Pierre M
J Clin Gastroenterol; 1991 Jun; 13(3):291-5. PubMed ID: 1676715
[TBL] [Abstract][Full Text] [Related]
10. Treatment of duodenal ulcer.
Eliakim R; Rachmilewitz D
Rev Clin Basic Pharm; 1985; 5(3-4):215-33. PubMed ID: 2881325
[TBL] [Abstract][Full Text] [Related]
11. [The comparative efficacy of ranitidine and famotidine in treating exacerbations of duodenal peptic ulcer].
Grigor'ev PIa; Isakov VA; Iakovenko EP
Klin Med (Mosk); 1992; 70(11-12):48-50. PubMed ID: 1294822
[No Abstract] [Full Text] [Related]
12. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of famotidine and ranitidine in duodenal ulcer].
Rohner HG; Gugler R; Kimmig JM; Schönekäs H
Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
[No Abstract] [Full Text] [Related]
14. [A combination of pirenzepine with ranitidine in the treatment of refractory duodenal ulcer].
Calabrò A; Salvadori G; Parenti S; Sani S; Ceccatelli P; Valentini P; Surrenti C
Minerva Dietol Gastroenterol; 1986; 32(3):291-5. PubMed ID: 3796871
[No Abstract] [Full Text] [Related]
15. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients.
Lezoche E; Vagni V; D'Alessandro MD; Mariani P; Carlei F; Lomanto D; Nardovino M; Martelli A; Speranza V
Drugs Exp Clin Res; 1987; 13(10):655-8. PubMed ID: 2892658
[TBL] [Abstract][Full Text] [Related]
16. [Is famotidine--the 3d generation H2 receptor antagonist--a step in progress in the treatment of duodenal ulcer?].
Stasiewicz J; Romatowski J; Kluz A; Szałaj W; Namiot Z
Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1684-6. PubMed ID: 3077455
[No Abstract] [Full Text] [Related]
17. Duodenal ulcer recurrences after treatment with pirenzepine and ranitidine.
Dzieniszewski J; Knapik Z; Pokora J; Kosieradzki W; Jarosz O; Woźniak-Stolarska B; Radwan P
Mater Med Pol; 1987; 19(3):196-9. PubMed ID: 3450981
[No Abstract] [Full Text] [Related]
18. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
[No Abstract] [Full Text] [Related]
19. [Clinical and economic analysis of the application of ranitidine and famotidine for treatment of duodenal ulcers].
Guseĭnzade MG
Eksp Klin Gastroenterol; 2005; (4):92-101. PubMed ID: 16255545
[No Abstract] [Full Text] [Related]
20. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
